Andrea Chamblee

Wilson Sonsini Goodrich & Rosati

Contact
View Bio
RSS

Latest Posts › FDA Approval

Share:

FDA Issues Draft Guidance to Facilitate Development of Human Gene Therapy, CAR T Cell, and Regenerative Medicine Products

The Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) updated its Guidance Agenda in June 2022, which provides that the agency plans to issue 18 guidance documents in 2022,...more

8/15/2022  /  Center for Biologics Evaluation and Research (CBER) , Clinical Trials , Controlled Substances , FDA Approval , Food and Drug Administration (FDA) , Life Sciences , Pharmaceutical Industry
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide